CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .7. NEW HORIZONS IN BETA-ADRENOCEPTOR BLOCKADE THERAPY - LABETALOL

被引：52

作者：

FRISHMAN, W

HALPRIN, S

机构：

来源：

关键词：

D O I：

10.1016/0002-8703(79)90294-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：660 / 665

页数：6

共 41 条

[1] A STUDY OF THE ADRENOTROPIC RECEPTORS
AHLQUIST, RP
[J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1948, 153 (03): : 586 - 600
[2] BERLIN LJ, 1972, LANCET, V1, P979
[3] BEWTRA A, 1975, J ALLERGY CLIN IMMUN, V55, P93
[4] BOAKES AJ, 1971, CLIN SCI, V40, P18
[5] BOAKES AJ, 1973, BRIT J PHARMACOL, V47, P673
[6] BOLLI P, 1976, BRIT J CLIN PHARMACO, V3, P765
[7] BRITTAIN RT, 1976, BRIT J CLIN PHARMACO, V3, P681
[8] CLINICAL INVESTIGATION OF AN ANTAGONIST AT ALPHA AND BETA-ADRENOCEPTORS-AH 5158A
COLLIER, JG
NACHEV, C
DAWNAY, NAH
ROBINSON, BF
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (02) : 286 - &
[9] PLASMA PROPRANOLOL LEVELS IN QUANTITATIVE ASSESSMENT OF BETA-ADRENERGIC BLOCKADE IN MAN
COLTART, DJ
SHAND, DG
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5725) : 731 - &
[10] DARGIE HJ, 1976, BRIT J CLIN PHARMACO, V3, P751